• Topotecan in First-Line Small Cell Lung Cancer: Clinical Ins

  2026-04-28

  This article reviews the clinical evaluation of Topotecan as a first-line treatment for small cell lung cancer (SCLC), focusing on its mechanism, efficacy, and toxicity profile compared to established regimens. The findings highlight Topotecan’s potential in combination therapies, its manageable toxicity, and implications for future research and clinical protocols.

• BQCA and M1 Signaling: Blueprint for Translational Breakthro

  2026-04-27

  This thought-leadership article explores how Benzyl Quinolone Carboxylic Acid (BQCA) enables precise, selective modulation of M1 muscarinic acetylcholine receptor signaling. Integrating mechanistic insights from recent landmark studies and protocol innovation, we chart a strategic pathway for translational researchers engaged in cognitive function modulation and Alzheimer's disease research. The piece uniquely bridges experimental validation, workflow optimization, and competitive positioning, offering actionable guidance beyond typical product summaries.

• Isradipine (Dynacirc): Applied Workflows in Neuro-Cardio Res

  2026-04-27

  Isradipine (Dynacirc) stands out as a selective L-type calcium channel blocker, empowering researchers in hypertension and neurodegeneration studies to dissect calcium signaling with precision. This guide translates recent literature and best practices into actionable workflows and troubleshooting strategies for maximizing the impact of Isradipine in experimental setups.

• (Z)-4-Hydroxytamoxifen: Advanced ER Modulation in Tumor Rela

  2026-04-26

  (Z)-4-Hydroxytamoxifen from APExBIO empowers researchers to dissect estrogen receptor signaling and model breast cancer relapse with precision. Explore protocol enhancements, troubleshooting strategies, and real-world workflows that set this potent ER modulator apart for translational research.

• IMPDH Inhibition Disrupts PEDV Replication via Metabolic Rew

  2026-04-25

  This study uncovers how porcine epidemic diarrhea virus (PEDV) exploits host IMPDH-dependent guanine nucleotide biosynthesis to enhance its replication. Genetic and pharmacological targeting of IMPDH, notably using Merimepodib (VX-497), significantly impairs PEDV proliferation, highlighting a promising host-directed antiviral strategy.

• Polybrene (Hexadimethrine Bromide): Enhancing Gene Delivery

  2026-04-24

  Polybrene (Hexadimethrine Bromide) 10 mg/mL from APExBIO revolutionizes viral gene delivery and lipid-mediated DNA transfection, especially in challenging cell lines. This guide details stepwise workflows, advanced applications, and troubleshooting tips to maximize reproducibility and precision in modern molecular biology research.

• Meropenem Trihydrate: Integrating Metabolomics for Advanced

  2026-04-24

  Explore how Meropenem trihydrate empowers cutting-edge antibiotic resistance studies by integrating LC-MS/MS metabolomics, offering new insights beyond standard protocols. Discover its unique role in deciphering resistant phenotypes and optimizing experimental workflows.

• Lactate-Driven HMGB1 Release in Sepsis: Mechanisms and Impli

  2026-04-23

  This study uncovers how elevated lactate levels promote HMGB1 lactylation, acetylation, and exosomal release from macrophages during polymicrobial sepsis. The findings clarify a causal link between metabolic alterations and inflammatory signaling, suggesting new intervention points for sepsis and inflammation research.

• Radicicol: Precision Hsp90 Inhibition for Metabolic and Canc

  2026-04-23

  Explore Radicicol, a potent Hsp90 inhibitor, in the context of adipogenesis, apoptosis, and inflammation models. This in-depth review uniquely integrates mechanistic insights and cross-comparisons to guide advanced assay design.

• Pam3CSK4 as a TLR1/2 Agonist: Integrating Neuro-Immune Modul

  2026-04-22

  Explore the scientific basis and advanced applications of Pam3CSK4 as a TLR1/2 agonist in immune cell activation. This article uniquely bridges innate immunity with emerging neuro-immune insights, offering deep protocol guidance and comparative analysis.

• Glutamine Modulates Hepatic T Cell Signaling via CD8A/LCK/LA

  2026-04-22

  This study elucidates how dietary glutamine supplementation modulates hepatic immune responses in piglets through T cell-mediated CD8A/LCK/LAT signaling, as revealed by transcriptomic, RT-qPCR, and Western blot analyses. The findings provide mechanistic insight into glutamine's immunomodulatory effects and lay groundwork for future investigations into liver immune regulation and nutritional interventions.

• Viral Regulation of RIPK3 Degradation and Necroptosis in Inf

  2026-04-21

  Liu et al. identify a class of orthopoxvirus proteins that induce proteasomal degradation of the necroptosis adaptor RIPK3, thereby suppressing necroptotic cell death and modulating virus-induced inflammation. This work reveals a novel viral immune evasion mechanism and highlights the evolutionary interplay between host cell death pathways and viral pathogenesis.

• Distinct Apoptotic Pathways in BMECs Induced by C. krusei Ph

  2026-04-21

  This study reveals that the yeast and hypha phases of Candida krusei induce apoptosis in bovine mammary epithelial cells (BMECs) via separate signaling routes: the yeast phase activates a mitochondrial pathway, while the hypha phase utilizes a death ligand/receptor pathway. The findings clarify the mechanistic diversity of pathogen-induced apoptosis and highlight key MAPK pathway components, informing future research and intervention strategies.

• Dovitinib (TKI-258): Strategic Advances in Translational Onc

  2026-04-20

  Explore how Dovitinib (TKI-258, CHIR-258) empowers translational cancer research by mechanistically targeting multiple RTKs, integrating apoptosis induction, and elevating experimental impact. This thought-leadership article bridges molecular insight, protocol design, and clinical trajectory, providing actionable guidance for research leaders.

• Nelfinavir Mesylate: Applied HIV-1 Protease Inhibitor for Re

  2026-04-20

  Nelfinavir Mesylate from APExBIO is a gold-standard HIV-1 protease inhibitor empowering both antiretroviral and ferroptosis research. This article delivers actionable protocol insights, troubleshooting strategies, and advanced use-cases, all grounded in the latest literature.

450 records 20/30 page Previous Next First page 上5页 1617181920 下5页 Last page